Search
Glumetinib
go.drugbank.com/drugs/DB15630InvestigationalGlumetinib is under investigation in clinical trial NCT04270591 (Assess the Anti-tumor Activity and Safety of Glumetinib in Patient With Advanced C-met-positive Non-small Cell Lung Cancer).
Benapenem
go.drugbank.com/drugs/DB18883InvestigationalBenapenem is under investigation in clinical trial NCT04505683 (A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (Cuti) or Acute Pyelonephritis
Cedirogant
go.drugbank.com/drugs/DB18951InvestigationalCedirogant is under investigation in clinical trial NCT05044234 (A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis
Forimtamig
go.drugbank.com/drugs/DB19015InvestigationalForimtamig is under investigation in clinical trial NCT06055075 (A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-based Treatment Combinations in Participants With Relapsed
Foscenvivint
go.drugbank.com/drugs/DB15034InvestigationalPRI-724 is under investigation in clinical trial NCT03620474 (Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis).
25-desacetylrifapentine
go.drugbank.com/drugs/DB15213Investigational25-desacetylrifapentine is under investigation in clinical trial NCT00023387 (TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine).
Ternidazole
go.drugbank.com/drugs/DB19951ExperimentalTernidazole is a small molecule drug. The usage of the INN stem '-nidazole' in the name indicates that Ternidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.
Bamnidazole
go.drugbank.com/drugs/DB19965ExperimentalBamnidazole is a small molecule drug. The usage of the INN stem '-nidazole' in the name indicates that Bamnidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.
Lificiguat
go.drugbank.com/drugs/DB19979ExperimentalLificiguat is a small molecule drug. The usage of the INN stem '-ciguat' in the name indicates that Lificiguat is a guanylate cyclase activator and stimulator.